# EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
> **ANDA203442** · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2020-05-15
## Drug
- **FDA Application Number:** ANDA203442
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
- **Generic name:** EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
- **Active ingredients:** EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MACLEODS PHARMS LTD
- **Manufacturer:** Macleods Pharmaceuticals Limited
- **First approval:** 2020-05-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203442)
---
*MORVS · CC0 1.0*